Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: A possible compensatory mechanism in Parkinson's disease

Frontiers in Systems Neuroscience

Volumn , Issue NOVEMBER 2011, 2011, Pages

  Blesa, Javier ^a,b   Juri, Carlos ^a,c   Garcia Cabezas, Miguel Á ^d,e   Adánez, Rebeca ^a,b   Sánchez González, Miguel Á ^d,e   Cavada, Carmen ^d,e   Obeso, José A ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

18F DOPA; Compensatory mechanisms; Dopaminergic; MPTP; Parkinson's disease; PET

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 6 FLUORODOPA F 18; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ASYMMETRY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HAPLORHINI; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MESENCEPHALON; MOTOR ACTIVITY; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY;

EID: 84856195961     PISSN: 16625137     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnsys.2011.00092     Document Type: Article

References (38)

1. Andersson, K., Schwarcz, R., and Fuxe K. (1980). Compensatory bilateral changes in dopamine turnover aftei striatal kainate lesion. Nature 283 94-96.
2. Beal, M. F. (2010). Parkinson's disease: a model dilemma. Nature 466, S8-S10
3. Bernheimer, H., Birkmayer, W., Horny-kiewicz, O., Jellinger, K., and Seit-elberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J.Neurol. Sci. 20,415-455.
4. Bezard, E., Dovero, S., Prunier, C. Ravenscroft, P., Chalon, S., Guil-loteau, D., Crossman, A. R., Bioulac B., Brotchie, J. M., and Gross, C Bezard E.(2001). Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J. Neurosci. 21, 6853-6861.
5. Bezard, E., Gross, C. E., and Brotchie, J M. (2003). Presymptomatic compensation in Parkinson's disease is no dopamine-mediated. Trends Neu-rosci. 26, 215-221.
6. Blesa, J., Juri, C., Collantes, M., Penue-las, I., Prieto, E., Iglesias, E., Marti-Climent, J., Arbizu, J., Zubieta, J L., Rodriguez-Oroz, M. C., Garcia-Garcia, D., Richter, J. A., Cavada C., and Obeso, J. A. (2010). Progression of dopaminergic depletion in a model of MPTP-induced Parkin-sonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study. Neurobiol. Dis. 38,456-463.
7. Boulet, S., Mounayar, S., Poupard, A. Bertrand, A., Jan, C., Pessiglione M., Hirsch, E. C., Feuerstein, C. Francois, C., Feger, J., Savasta, M. and Tremblay, L. (2008). Behaviora recovery in MPTP-treated monkeys neurochemical mechanisms studied by intrastriatal microdialysis. J. Neu-rosci. 28, 9575-9584.
8. Brotchie, J., and Fitzer-Attas, C (2009). Mechanisms compensating for dopamine loss in early Parkinson disease. Neurology 72, S32-S38.
9. Castellano, M. A., Rivero, F. L., and Rodriguez, M. (1993). Spontaneous firing of nigrostriatal dopaminergic neurons in split-brain rats. Neurosci Lett. 162, 1-4.
10. Cavada, C., Company, T., Hernandez-Gonzalez, A., and Reinoso-Suarez F.(1995). Acetylcholinesterase histo- chemistry in the macaque thalamus reveals territories selectively con- nected to frontal, parietal and tem- poral association cortices. J. Chem Neuroanat. 8, 245-257.
11. Collantes, M., Prieto, E., Penuelas, I., Blesa, J., Juri, C., Marti-Climent, J. M., Quincoces, G., Arbizu, J., Riverol, M., Zubieta, J. L., Rodriguez-Oroz, M. C., Luquin, M. R., Richter, J. A., and Obeso, J. A. (2009). New MRI, 18F-DOPA and 11C-(+)-alpha-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: advantages to improve PET quantification. Neuroimage 47, 533-539.
12. Dickson, D., Braak, H., Duda, J., Duyckaerts, C., Gasser, T., Halli-day, G., Hardy, J., Leverenz, J., Del Tredici, K., Wszolek, Z., and Litvan, I. (2009). Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 8, 1150-1157.
13. Djaldetti, R., Ziv, I., and Melamed, E. (2006). The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol. 5, 796-802.
14. Fass, B., and Butcher, L. L. (1981). Evidence for a crossed nigrostriatal pathway in rats. Neurosci. Lett. 22, 109-113.
15. Fearnley, J., and Lees, A. (1991). Ageing and Parkinson's disease: substan-tia nigra regional selectivity. Brain 114(Pt5), 2283-2301.
16. Fearnley, J. M., and Lees, A. J. (1990). Striatonigral degeneration. Aclinico-pathological study. Brain 113(Pt 6), 1823-1842.de
17. Gonzalez-Hernandez, T., Barroso-Chinea, P., and Rodriguez, M. (2004). Response of the GABAer- gic and dopaminergic mesostriatal projections to the lesion of the con-tralateral dopaminergic mesostriatal pathway in the rat. Mov. Disord. 19, 1029-1042.
18. Halliday, G., Hely, M., Reid, W., and Morris, J. (2008). The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol. 115, 409-415.
19. Hornykiewicz, O. (1975). Brain monoamines and parkinsonism. Psychopharmacol. Bull. 11, 34-35.
20. Hornykiewicz, O., and Kish, S. J. (1987). Biochemical pathophysiol-ogy of Parkinson's disease. Adv. Neurol. 45, 19-34.
21. Juri, C., Arbizu, J., Blesa, J., Rodriguez Oroz, M. C., Prieto, E., Igle Sias, E., Collantes, M., Richter, J. A., Penuelas, I., and Obeso, J. A. (2009). Reciprocal Relationship Between the Striatum Bilaterally and Compensation of Dopaminergic Depletion in Early Parkinson's Disease. An 18F-FDOPA PET Study. Program 52024/J34 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience.
22. Kurlan, R., Kim, M., and Gash, D. (1991). Oral levodopa dose-response study in MPTP-induced hemiparkin-sonian monkeys: assessment with a new rating scale for monkey parkin-sonism. Mov. Disord. 6, 111-118.
23. Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., Lee, C., McKenzie, J., McCormick, S., Samii, A., Troiano, A., Ruth, T., Sossi, V., De la Fuente, Fernandez, R., Calne, D., and Stoessl, A. (2009). Longitudinal progression ofsporadic Parkinson's disease: a multi-tracer positron emission tomographystudy. Brain 132,2970-2979.
24. Narang, N., Hunt, M., Pundt, L., Alburges, M., and Wamsley, J. (1993). Unilateral ibotenic acid lesion of the caudate putamen results in D2 receptor alterations on the contralateral side. Exp. Neurol. 121, 40-47.
25. Nieoullon, A., Cheramy, A., and Glowinski, J. (1977). Interdependence of the nigrostriatal dopamin-ergic systems on the two sides of the brain in the cat. Science 198, 416-418.
26. Obeso, J. A., Rodriguez-Oroz, M. C., Lanciego, J. L., and Rodriguez Diaz, M. (2004). How does Parkinson's disease begin? The role of compensatory mechanisms. Trends Neurosci. 27,125-127; author reply 127-128.
27. Perier, C., Agid, Y., Hirsch, E. C., and Feger, J. (2000). Ipsilateral and con-tralateral subthalamic activity after unilateral dopaminergic lesion. Neu- roreport 11, 3275-3278.
28. Pifl, C., and Hornykiewicz, O. (2006). Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochem. Int. 49, 519-524.
29. Poewe, W. (2006). The natural history of Parkinson's disease. J. Neurol. 253(Suppl. 7), VII2-VII6.
30. Rodriguez, M., Castellano, M. A., and Palarea, M. D. (1990). Inter- hemispheric regulation of dopamin-ergic ascending systems. Life Sci. 47, 377-384.
31. Rodriguez, M., and Gonzalez-Hernandez, T. (1999). Electro-physiological and morphological evidence for a GABAergic nigros-triatal pathway. J. Neurosci. 19, 4682-4694.
32. Roedter, A., Winkler, C., Samii, M., Walter, G. F., Brandis, A., and Nikkhah, G. (2001). Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for inter-hemispheric functional coupling of the two nigrostriatal pathways. J. Comp. Neurol. 432, 217-229.
33. Sanchez-Gonzalez, M. A., Garcia-Cabezas, M. A., Rico, B., and Cavada, C. (2005). The primate thalamus is a key target for brain dopamine. J. Neurosci. 25, 6076-6083.
34. Tang, C. C., Poston, K. L., Dhawan, V., and Eidelberg, D. (2011). Abnor- malitiesinmetabolicnetworkactivity precedetheonsetofmotorsymptoms in Parkinson's disease. J. Neurosci. 30, 1049-1056.
35. Van Camp, N., Vreys, R., Van Laere, K., Lauwers, E., Beque, D., Ver-hoye, M., Casteels, C., Verbruggen, A., Debyser, Z., Mortelmans, L., Sijbers, J., Nuyts, J., Baekelandt, V., and Van der Linden, A. (2010). Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with muSPECT and quantitative MRI. MAGMA 23, 65-75.
36. Zigmond, M. J. (1997). Do compensatory processes under lie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiol. Dis. 4, 247-253.
37. Zigmond, M. J., Abercrombie, E.,Berger, T. W., Grace, A. A., and Stricker, E. M. (1990). Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 13, 290-296.
38. Zigmond, M. J., Berger, T. W., Grace, A. A., and Stricker, E. M. (1989). Compensatory responses to nigros-triatal bundle injury. Studies with 6- hydroxydopamine in an animal model of parkinsonism. Mol. Chem. Neuropathol. 10, 185-200.